title: Immunotherapy and gene therapy in prostate cancer treatment.
abstract: There are few methods bringing several relatively recent advances in therapy of certain types of prostate cancer. Belonging to personalized therapies, they use cells (normal or pathologic) from the patient, modify and reintroduce them in the patient's body, leading to an increased efficiency against the neoplastic tissue, proving to increase the patient's lifespan and/ or tumor progression.
authors.affiliation: "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
authors.forename: T
authors.initials: T
authors.lastname: Grozescu
authors.affiliation: "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
authors.forename: F
authors.initials: F
authors.lastname: Popa
mesh_terms: D019264:Adoptive Transfer; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D015316:Genetic Therapy; D006801:Humans; D007167:Immunotherapy; D008297:Male; D050130:Oncolytic Virotherapy; D011471:Prostatic Neoplasms / Q000235:genetics / Q000276:immunology* / Q000473:pathology / Q000628:therapy*
chemical_list: D000911:Antibodies, Monoclonal
keywords: gene therapy; immunotherapy; lifespan; neoplastic tissue; prostate cancer treatment